JGBs Gain as Moderna CEO’s Omicron Warning Lifts Safe-Haven Assets

TOKYO — Japanese government bonds (JGBs) gained on Tuesday, in line with U.S. Treasuries, after the chief of U.S. drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant as it has been with other types. Read More